Literature DB >> 11098861

Update: outbreak of Rift Valley Fever--Saudi Arabia, August-November 2000.

.   

Abstract

On September 10, 2000, the Ministry of Health (MOH), Kingdom of Saudi Arabia and subsequently, the MOH of Yemen began receiving reports of unexplained hemorrhagic fever in humans and associated animal deaths and abortions from the far western Saudi-Yemeni border region. These cases subsequently were confirmed as Rift Valley fever (RVF), the first such cases on the Arabian peninsula. This report updates the findings of the ongoing investigation conducted by the Saudi Arabian MOH in collaboration with CDC and the National Institute of Virology, South Africa.

Entities:  

Mesh:

Year:  2000        PMID: 11098861

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  29 in total

1.  The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus.

Authors:  José-Carlos Fernandez; Agnès Billecocq; Jean Paul Durand; Catherine Cêtre-Sossah; Eric Cardinale; Philippe Marianneau; Michel Pépin; Noël Tordo; Michèle Bouloy
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

2.  Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system.

Authors:  Tetsuro Ikegami; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry.

Authors:  Brian H Bird; Marina L Khristova; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

4.  Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis.

Authors:  Todd M Bell; Virginia Espina; Svetlana Senina; Caitlin Woodson; Ashwini Brahms; Brian Carey; Shih-Chao Lin; Lindsay Lundberg; Chelsea Pinkham; Alan Baer; Claudius Mueller; Elizabeth A Chlipala; Faye Sharman; Cynthia de la Fuente; Lance Liotta; Kylene Kehn-Hall
Journal:  Antiviral Res       Date:  2017-04-23       Impact factor: 5.970

5.  Role of Culex and Anopheles mosquito species as potential vectors of rift valley fever virus in Sudan outbreak, 2007.

Authors:  Alaaeddeen M Seufi; Fatma H Galal
Journal:  BMC Infect Dis       Date:  2010-03-11       Impact factor: 3.090

6.  Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions.

Authors:  A Desiree LaBeaud; Yoshitsugu Ochiai; C J Peters; Eric M Muchiri; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2007-05       Impact factor: 2.345

7.  Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus.

Authors:  Brian H Bird; Darcy A Bawiec; Thomas G Ksiazek; Trevor R Shoemaker; Stuart T Nichol
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

8.  Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya.

Authors:  A Desiree LaBeaud; Eric M Muchiri; Malik Ndzovu; Mariam T Mwanje; Samuel Muiruri; Clarence J Peters; Charles H King
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

9.  Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01.

Authors:  Trevor Shoemaker; Carla Boulianne; Martin J Vincent; Linda Pezzanite; Mohammed M Al-Qahtani; Yagub Al-Mazrou; Ali S Khan; Pierre E Rollin; Robert Swanepoel; Thomas G Ksiazek; Stuart T Nichol
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

10.  Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003.

Authors:  Ousmane Faye; Mawlouth Diallo; Djibril Diop; O Elmamy Bezeid; Hampathé Bâ; Mbayame Niang; Ibrahima Dia; Sid Ahmed Ould Mohamed; Kader Ndiaye; Diawo Diallo; Peinda Ogo Ly; Boubacar Diallo; Pierre Nabeth; François Simon; Baïdy Lô; Ousmane Madiagne Diop
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.